Go Back
![Relapse Refractory Hodgkin lymphoma [slides 2023]](https://oncologytubecom.cdn.ypt.me/videos/video_230927172435_vb190/video_230927172435_vb190_thumbsV2_jpg.webp?cache=1695854069_1695854069 "Relapse Refractory Hodgkin lymphoma [slides 2023]")
![Pacritinib: Anemia Mechanisms in MPNs -NFKB/ACVR1- [2023 SLIDES]](https://oncologytubecom.cdn.ypt.me/videos/video_230927060921_v7afe/video_230927060921_v7afe_thumbsV2_jpg.webp?cache=1695813885_1695813885 "Pacritinib: Anemia Mechanisms in MPNs -NFKB/ACVR1- [2023 SLIDES]")
![MRD: Revolutionizing Lymphoma Care - [2023 SLIDES]](https://oncologytubecom.cdn.ypt.me/videos/video_230927054035_v241b/video_230927054035_v241b_thumbsV2_jpg.webp?cache=1695811726_1695811726 "MRD: Revolutionizing Lymphoma Care - [2023 SLIDES]")
![Myeloproliferative Neoplasms: WHO/ICC Systems - [2023 SLIDES]](https://oncologytubecom.cdn.ypt.me/videos/video_230926080309_va10b/video_230926080309_va10b_thumbsV2_jpg.webp?cache=1695733816_1695733816 "Myeloproliferative Neoplasms: WHO/ICC Systems - [2023 SLIDES]")
![Follicular Lymphoma: Treatment and Quality of Life-[2023 SLIDES]](https://oncologytubecom.cdn.ypt.me/videos/video_230926060511_v7bd1/video_230926060511_v7bd1_thumbsV2_jpg.webp?cache=1695833789_1695833789 "Follicular Lymphoma: Treatment and Quality of Life-[2023 SLIDES]")
![Tyrosine Kinase Inhibitors in Mastocytosis-[2023 SLIDES]](https://oncologytubecom.cdn.ypt.me/videos/video_230925095036_va9dd/video_230925095036_va9dd_thumbsV2_jpg.webp?cache=1695654869_1695654869 "Tyrosine Kinase Inhibitors in Mastocytosis-[2023 SLIDES]")
![Genomic Profiling and Strategies for Blood Cancer- [2023 SLIDES]](https://oncologytubecom.cdn.ypt.me/videos/video_230925072638_vcaaf/video_230925072638_vcaaf_thumbsV2_jpg.webp?cache=1695655076_1695655076 "Genomic Profiling and Strategies for Blood Cancer- [2023 SLIDES]")
![Myeloid Neoplasms with Eosinophilia and TK Fusion Genes [Slides] 2023](https://oncologytubecom.cdn.ypt.me/videos/video_230922093727_vb99f/video_230922093727_vb99f_thumbsV2_jpg.webp?cache=1695401266_1695401266 "Myeloid Neoplasms with Eosinophilia and TK Fusion Genes [Slides] 2023")
![Diffuse Large B Cell Lymphoma-What is best for risk prediction and treatment? [2023 Slides].](https://oncologytubecom.cdn.ypt.me/videos/video_230921113513_v507e/video_230921113513_v507e_thumbsV2_jpg.webp?cache=1695393687_1695393687 "Diffuse Large B Cell Lymphoma-What is best for risk prediction and treatment? [2023 Slides].")
Live
Upcoming Events
Videos Shown By Date Added (newest) (Page 1) Up
Relapse Refractory Hodgkin lymphoma [slides 2023]
Are there any specific patient subgroups who may benefit more or less from TTFields treatment?
What are the implications of the LUNAR trial findings for clinical practice?
Pacritinib: Anemia Mechanisms in MPNs -NFKB/ACVR1- [2023 SLIDES]
MRD: Revolutionizing Lymphoma Care - [2023 SLIDES]
What were the key findings of the LUNAR trial? - Ticiana Leal, MD
How do tumor treating fields (TTFields) work? - Ticiana Leal MD
Myeloproliferative Neoplasms: WHO/ICC Systems - [2023 SLIDES]
Follicular Lymphoma: Treatment and Quality of Life-[2023 SLIDES]
Tyrosine Kinase Inhibitors in Mastocytosis-[2023 SLIDES]
Genomic Profiling and Strategies for Blood Cancer- [2023 SLIDES]
Myeloid Neoplasms with Eosinophilia and TK Fusion Genes [Slides] 2023
Diffuse Large B Cell Lymphoma-What is best for risk prediction and treatment? [2023 Slides].
Checkmate 227 Reveals Six-Year Survival Advantages of Nivolumab + Ipilimumab in mNSCLC
FLAURA2: Should this Positive Trial Change Practice for EGFRm+ NSCLC
Akadeum: What is a T Cell Activation & Expansion Kit?
TTFields Phase 3 LUNAR Trial Results in Metastatic NSCLC - Ticiana Leal, MD
What is the significance OneOncology's pathways?
irAEs and TRBV polymorphisms - Interview with Timothy Looney, PhD
Cancer Immunotherapy Advances: Jill O’Donnell - Tormey, PhD
TIBSOVO's Potential: Susan Pandya, MD, on FDA Priority Review for IDH1-Mutated MDS
Lonsurf: FDA Approval with Bevacizumab - Marwan Fakih, MD
CD8 T cells effectively kill cancer cells - Joshua Brody, MD
Axatilimab in Chronic Graft-Versus-Host Disease AGAVE 201 Results.